Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06434948 · ClinicalTrials.gov registry record · Phase 2
The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery
A Phase 2 study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT06434948 is a Phase 2 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 1 participants.
The verdict
NCT06434948, a Phase 2 study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether giving omega-3 fatty acids prior to and after cardiac bypass surgeries decreases the incidence of postoperative delirium in patients aged 65 and over.
Interventions
- DRUG Omega-3 Ethyl Esters 4 g
- DRUG Omega-3 Ethyl Esters 2 g
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-04-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06434948
The ClinicalTrials.gov registry entry for NCT06434948 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omega-3 Ethyl Esters 4 g is the first listed.
NCT06434948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06434948 about?
NCT06434948 is a clinical study titled "The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery". The purpose of this study is to determine whether giving omega-3 fatty acids prior to and after cardiac bypass surgeries decreases the incidence of postoperative delirium in patients aged 65 and over.
What is the current status of trial NCT06434948?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2026-03-03. Estimated completion is 2026-04-29.
What interventions are being tested in trial NCT06434948?
The interventions under investigation include: Omega-3 Ethyl Esters 4 g (DRUG), Omega-3 Ethyl Esters 2 g (DRUG).
Who is sponsoring clinical trial NCT06434948?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.